IDXX | NASDAQ
Next Earnings: Jul 31, 2026
Company Overview:
10 Year IDXX Performance Metrics:
Unlock All Reports & Research Dividend Stocks.
[lev_ptables no_sale]IDXX Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
Projected Future Returns & Dividends for IDXX
Based on past 10-year performance, here are IDXX growth metrics:
Share price CAGR of +19.49%
Dividend CAGR of +0%
Using IDXX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| IDXX (DRIP) | IDXX - No DRIP | |
|---|---|---|
| Current Price | $554.72 | $554.72 |
| Start Shares | 18.03 | 18.03 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 18.03 | 18.03 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $3,290.71 | $554.72 |
| Total Dividends | $0 | $0 |
| Final Value | $59,322 | $10,000 |
NOTE: Above numbers are our estimate based on IDXX's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
[lev_ptables no_sale]Company Info
IDEXX Laboratories, Inc. (IDXX) had its IPO on 1991-06-21, and is trader on NASDAQ stock exchange.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
IDXX website: https://www.idexx.com
